Body Height
OSA risk in middle age linked to early childhood, adulthood BMI, weight gain
BOSTON — Adults who experienced BMI or weight gains between age 2 years and 5 years, as well as after age 11 years, faced increased odds for high obstructive sleep apnea risk, according to data presented at the CHEST Annual Meeting.
Oral achondroplasia therapy receives FDA breakthrough therapy designation
An oral medication to treat children with achondroplasia has received breakthrough therapy designation from the FDA, BridgeBio Pharma announced.
Children with atopic dermatitis may experience growth hinderance
SAN DIEGO — Researchers found that children with moderate to severe atopic dermatitis have a higher mean weight and BMI, but a lower mean height, than healthy children, according to a poster presented here.
FDA expands indication for vosoritide to include children of all ages with achondroplasia
The FDA has expanded its accelerated approval of an injectable therapy for treating achondroplasia to include children of all ages, according to a press release.
Children with higher genetic risk for PCOS more likely to develop obesity
Children and adolescents with a high polygenic risk score for polycystic ovary syndrome tend to have a higher BMI and are more likely to develop obesity, according to study data.
Azstarys improves sleep in children with ADHD, no significant impact on growth
Azstarys improved sleep habits and did not affect growth rates in children with ADHD, according to two recent studies.
Oral medication boosts annualized height velocity among children with GH deficiency
Children with idiopathic pediatric growth hormone deficiency had an increase in annualized height velocity after 6 months of receiving a daily oral GH therapy, according to a speaker.
Late cystic fibrosis diagnosis linked to lower weight, shorter height in early years
Infants with a late diagnosis for cystic fibrosis were more likely to be behind in their weight and height at 1 year and height at 3 and 5 years, according to a poster presented at the North American Cystic Fibrosis Conference.
GnRH analogue plus testosterone does not suppress adult height for transgender boys
Most transgender boys reach their predicted adult height after treatment with gonadotropin-releasing hormone analogues and testosterone therapy, according to data published in The Journal of Clinical Endocrinology & Metabolism.
Height may impact risk for common medical conditions
A person’s height appeared to impact their risk for a variety of common diseases, according to findings published in PLOS Genetics.